How is the Boundless Bio Inc. today?

The Boundless Bio Inc. today is trading in the down by -1.28% at 1.54.

How has Boundless Bio Inc. performed historically?

The Boundless Bio Inc. is currently trading down -1.28% on an intraday basis in the past week the index fell -8.88%. The index has been down -21.43% in the past quarter and fell -86.03% in the past year. You can view this in the overview section.

What is Boundless Bio Inc. Annual Net Profit?

Boundless Bio Inc. Annual Net Profit fell 32.22% in the last year to $65.36 M. Its sector's average net profit growth for the last fiscal year was -11.13%.

What is Boundless Bio Inc. Price to Earning Ratio?

Boundless Bio Inc. Price to Earning Ratio is -0.52, which is negative.

What is Boundless Bio Inc. Stock Price?

Boundless Bio Inc. Stock Price fell 86.03% and underperformed its sector by 97.91% in the past year.

What is Boundless Bio Inc. Quarterly Net profit?

Boundless Bio Inc. Quarterly Net profit fell 2.13% YoY to $15.76 M. Its sector's average net profit growth YoY for the quarter was -212.2%.

What is Boundless Bio Inc. Debt to Equity Ratio?

Boundless Bio Inc. Debt to Equity Ratio of 0.32 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Boundless Bio Inc. Return on Equity(ROE)?

Boundless Bio Inc. Return on Equity(ROE) for the last financial year was -554.86%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Boundless Bio Inc. Mutual Fund Holding?

Boundless Bio Inc. Mutual Fund Holding increased by 0.29% in the last quarter to 23.97.

What is Boundless Bio Inc. Institutional Holding?

Boundless Bio Inc. Institutional Holding decreased by 1.13% in the last quarter to 60.09.

Boundless Bio Inc. XNAS: BOLD

Boundless Bio Inc. Live Share Price Today, Share Analysis and Chart

Name: Boundless Bio Inc.: Is Infosys Ltd. worth buying?
Item: Boundless Bio Inc.
Rating: 1.50058325
Author: Trendlyne DVM scores

about

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a ...

1.54 -0.02 (-1.28%)

87.38% Fall from 52W High

18,242 XNAS Volume

XNAS 23 May, 2025 11:49 AM (EDT)

Board Meeting

The next board meeting for Boundless Bio Inc. is on 30 May 2025 for the purpose of Boundless Bio Inc First Quarter Earnings Results for 2025 See details

Not Eligible

Expensive Valuation

15.8 / 100

Technically Neutral

44.2 / 100

No estimates available

Boundless Bio Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Boundless Bio Inc. Live Share Price Today, Share Analysis and Chart

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a ...

87.38% Fall from 52W High

SWOT Analysis

Boundless Bio Inc. Live Price Chart

Boundless Bio Inc. FAQ

How is Boundless Bio Inc. today?

Boundless Bio Inc. today is trading in the red, and is down by -1.28% at 1.54.

How has Boundless Bio Inc. performed historically?

Boundless Bio Inc. is currently trading down -1.28% on an intraday basis. In the past week the stock fell -8.88%. stock has been down -21.43% in the past quarter and fell -86.03% in the past year. You can view this in the overview section.